BioMarin Pharmaceutical (Nasdaq: BMRN) develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Recent Mentions on Fool.com
- Why a Failure By BioMarin Caused Sarepta's Shares to Spike 53% in November
- BioMarin's DMD Drug Faces Obstacles Tomorrow
- If You're in Your 50s, Consider Buying These Stocks
- 3 Specialty-Drug Makers Trying to Spark Investor Interest -- Are They Buys?
- BioMarin Pharmaceutical Inc. Earnings: Pushing Toward Profitability